TSTickerStar
Company alerts/MOVE
MOVE company alerts

MOVE updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for MOVE. Subscribe to MOVE alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Official-source feed

Recent MOVE alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

Company updateOfficial company source

Corvex signs $103 million take-or-pay NVIDIA Blackwell capacity agreement

Corvex announced a definitive three-year, $103 million take-or-pay agreement to provide NVIDIA Blackwell computing capacity to an unnamed scaled AI inference platform, with the full contract value committed regardless of utilization. The approximately $78 million deployment is expected to be funded by a $26 million customer prepayment and $38 million of committed USD.AI debt financing, covering more than 80% of the cost, with Corvex intending to fund the remaining $14 million; the three-year asset-backed loan is...

Read source-backed brief
SEC filingSEC filing

MOVE 10-Q filed 2026-11-12 | Key takeaways

MOVE filed its 10-Q; the most relevant disclosure change is added Risk factors - Goodwill impairment: The company disclosed that goodwill of $519.2 million (83% of total assets) was recognized in connection with the Merger, and the recent decline in market price of common stock from $21.71 on June 30, 2026 to $5.05 on November 9, 2026 could result in a goodwil. Customer concentration: Customer A represented 72% of revenue; Customer A represented 69% of revenue.

Read source-backed brief
Company updateOfficial company source

Corvex Reports Q3 2026 Results; Revenue $5.0M, Adjusted EBITDA $(3.2)M

Corvex, Inc. reported Q3 2026 total revenue of $5.0 million and adjusted EBITDA of $(3.2) million; net loss was $(17.5) million or $(0.60) per share. The company noted that prior-year periods are not directly comparable due to the June 30, 2026 transfer of legacy healthcare assets, with Q3 2025 revenue of only $80,000 from the discontinued business. Cash and cash equivalents were $42.0 million at September 30, 2026, with $7.0 million in cash used in operating activities during the quarter. The company has approx...

Read source-backed brief
Debt offeringSEC filing

Corvex enters $250 million at-the-market sales agreement with Chardan Capital Markets

On October 14, 2026, Corvex, Inc. entered into an At-the-Market Sales Agreement with Chardan Capital Markets LLC as sales agent, pursuant to which the Company may offer and sell from time to time shares of its common stock having an aggregate offering price of up to $250,000,000. The Company will pay the Agent a commission of 2.5% of the aggregate gross proceeds from sales under the offering. Shares are being offered under the Company's effective Form S-3 shelf registration statement (File No. 333-298769), and a...

Read source-backed brief